Trial Profile
To Define the Role of PDEV in Mediating the Decreased GFR and Attenuated Renal Sodium and cGMP Excretory Response to Acute Saline Volume Expansion in PSD and PDD With Renal Dysfunction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary) ; Tadalafil (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 13 Mar 2012 New trial record